Your cart is currently empty!
Therapeutic Neovascularization – Quo Vadis? by Elisabeth Deindl, ISBN-13: 978-1402059544
Therapeutic Neovascularization – Quo Vadis? by Elisabeth Deindl, ISBN-10: 978-1402059544 [PDF eBook eTextbook] Publisher: Springer; 2007th edition (June 4, 2007) Language: English 272 pages ISBN-10: 9781402059544 ISBN-13: 978-1402059544 This collection of current and future concepts of neovascularization offers fascinating insights into refining a powerful therapeutic tool which has not yet had the chance […]
Description
Therapeutic Neovascularization – Quo Vadis? by Elisabeth Deindl, ISBN-10: 978-1402059544
[PDF eBook eTextbook]
- Publisher: Springer; 2007th edition (June 4, 2007)
- Language: English
- 272 pages
- ISBN-10: 9781402059544
- ISBN-13: 978-1402059544
This collection of current and future concepts of neovascularization offers fascinating insights into refining a powerful therapeutic tool which has not yet had the chance to live up to the expectations and needs of the medical community. It examines current refinements in the fundamental concept of neovascularization and describes the most recent developments, which in the future might pave the way towards a new era of therapeutic applications.
What makes us different?
• Instant Download
• Always Competitive Pricing
• 100% Privacy
• FREE Sample Available
• 24-7 LIVE Customer Support
Related products
-
A Compendium of Neuropsychological Tests 3rd Edition, ISBN-13: 978-0195159578
Original price was: $50.00.$14.99Current price is: $14.99. -
A Photographic Atlas for the Anatomy and Physiology Laboratory 7th Edition, ISBN-13: 978-0895828750
Original price was: $50.00.$14.99Current price is: $14.99. -
A Visual Analogy Guide to Human Anatomy & Physiology by Paul A. Krieger, 1st Edition, ISBN-13: 978-0895828019
Original price was: $50.00.$24.99Current price is: $24.99. -
Advanced Health Assessment and Diagnostic Reasoning 3rd Edition, ISBN-13:978-1284105377
Original price was: $50.00.$19.99Current price is: $19.99.
Reviews
There are no reviews yet.